Long-term outcomes of Sleeping Beauty-generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas.

ABSTRACT:

SUBMITTER: Srour SA 

PROVIDER: S-EPMC8212349 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature